1000-7431
2011 Issue 9
Screening of candidate proteins interacting with translationally controlled tumor protein by yeast two-hybrid method
ZHANG Guo-shou;LUO Shun-feng;WU Yan-bin;CHI Min-hui;LIU Jing-feng Department of Liver Surgery;Liver Center of First Affiliated Hospital;Fujian Medical University;Fuzhou 350004;China
ZHANG Guo-shou;LUO Shun-feng;WU Yan-bin;CHI Min-hui;LIU Jing-feng Department of Liver Surgery;Liver Center of First Affiliated Hospital;Fujian Medical University;Fuzhou 350004;China
..............page:794-799
Small interference RNA-mediated mesothelin silencing promotes apoptosis of cisplatin-resistant SKOV3/cDDP cells
LIU Li-ping1;WU Xiao-hua1;2;LIANG Hong-xia2 1.Department of Obstetrics and Gynecology;Hebei Medical University;Shijiazhuang 050000;China;2.Department of Obstetrics and Gynecology;Bethune International Peace Hospital;Chinese People’s Liberation Army;Shijiazhuang 050082;China
LIU Li-ping1;WU Xiao-hua1;2;LIANG Hong-xia2 1.Department of Obstetrics and Gynecology;Hebei Medical University;Shijiazhuang 050000;China;2.Department of Obstetrics and Gynecology;Bethune International Peace Hospital;Chinese People’s Liberation Army;Shijiazhuang 050082;China
..............page:777-782
The effects of VEGF and Smac/DIABLO on apoptosis and chemosensitivity of human glioma cells
CHEN Yin1;MA Jie2;WU Guo-hua3;CAI Wei2 1.Wenzhou Medical College;Wenzhou 325035;China;2.Department of Pediatric Surgery;Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 200092;China;3.Department of Oncology;Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 200092;China
CHEN Yin1;MA Jie2;WU Guo-hua3;CAI Wei2 1.Wenzhou Medical College;Wenzhou 325035;China;2.Department of Pediatric Surgery;Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 200092;China;3.Department of Oncology;Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 200092;China
..............page:800-805
Laparoscopic jejunostomy with ENDO STITCH?:Report of 4 cases of esophageal cancer
ZHANG Jie1;2;PAN Yun-jian1;2;CHEN Hai-quan1;2;LUKETICH James3;YE Ting1;2 1.Department of Toracic Surgery;Shanghai Cancer Center;Fudan University;Shanghai 200032;China;2.Department of Oncology;Shanghai Medical School;Fudan University;Shanghai 200032;China;3.Department of Cardiothoracic Surgery;Division of Thoracic Surgery;University of Pittsburg Medical Center;Pittsburg 15213;USA
ZHANG Jie1;2;PAN Yun-jian1;2;CHEN Hai-quan1;2;LUKETICH James3;YE Ting1;2 1.Department of Toracic Surgery;Shanghai Cancer Center;Fudan University;Shanghai 200032;China;2.Department of Oncology;Shanghai Medical School;Fudan University;Shanghai 200032;China;3.Department of Cardiothoracic Surgery;Division of Thoracic Surgery;University of Pittsburg Medical Center;Pittsburg 15213;USA
..............page:856-858
The regulation effects of miR-181a on the target gene PRDM1 in esophageal carcinoma cell line EC9706
LI Shu-jun1;ZHANG Li-jun2;ZHANG Hai-long2;NIU Xiu-lan2;LIU Li-na1;WEI Su-xia1;ZHANG He-lin1 1.Department of Thoracic Surgery;Second Hospital of Hebei Medical University;Shijiazhuang 050051;China;2.Department of Oncology;Shexian Traditional Chinese Medicine Hospital;Handan 056400;China
LI Shu-jun1;ZHANG Li-jun2;ZHANG Hai-long2;NIU Xiu-lan2;LIU Li-na1;WEI Su-xia1;ZHANG He-lin1 1.Department of Thoracic Surgery;Second Hospital of Hebei Medical University;Shijiazhuang 050051;China;2.Department of Oncology;Shexian Traditional Chinese Medicine Hospital;Handan 056400;China
..............page:813-818
..............page:876-880
..............page:799
Comparison of efficacy between FOLFOX4 regimen and FLP regimen as adjuvant chemotherapy for carcinoma of esophagogastric junction
YANG Zi-xin;WANG Long;WANG Yu-dong;ZUO Jing;LIU Wei;WANG Shu-qin;WANG Yu-hua;LIU Feng-ling;WEI Su-ju Department of Medical Oncology;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China
YANG Zi-xin;WANG Long;WANG Yu-dong;ZUO Jing;LIU Wei;WANG Shu-qin;WANG Yu-hua;LIU Feng-ling;WEI Su-ju Department of Medical Oncology;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China
..............page:851-855
The expression of GPC3 in human malignant cancers and its potential clinical application
RUAN Jian;ZHENG Da-yong;LUO Rong-cheng Oncology Center;Nanfang Hospital;Southern Medical University;Guangzhou 510515;China
RUAN Jian;ZHENG Da-yong;LUO Rong-cheng Oncology Center;Nanfang Hospital;Southern Medical University;Guangzhou 510515;China
..............page:863-866
The effects of endogenic field hyperthermia combined with intraperitoneal chemotherapy on the treatment outcomes and serum tumor markers of patients with advanced gastric cancer and celiac lymph node metastasis
SHENG Qing;JIN Yun-jie;ZHU Ji-hua;YAO Xiao-xiang;ZHU Lin-yu;WU Jian-yi;HUANG Xiao-dong Department of Oncology;Shanghai Putuo People’s Hospital;Shanghai 200060;China
SHENG Qing;JIN Yun-jie;ZHU Ji-hua;YAO Xiao-xiang;ZHU Lin-yu;WU Jian-yi;HUANG Xiao-dong Department of Oncology;Shanghai Putuo People’s Hospital;Shanghai 200060;China
..............page:859-862
Advances in research of long noncoding RNAs in hepatic carcinoma
SUN Tian-tian;FANG Jing-yuan Renji Hospital;Shanghai Jiaotong University School of Medicine;Shanghai Institute of Digestive Disease;Shanghai 200001;China
SUN Tian-tian;FANG Jing-yuan Renji Hospital;Shanghai Jiaotong University School of Medicine;Shanghai Institute of Digestive Disease;Shanghai 200001;China
..............page:867-870
A seventeen-year prospective cohort study on association of hepatitis B virus e antigen with the risk of hepatocellular carcinoma
SUN Yan1;CHEN Tao-yang1;LU Pei-xin1;WANG Jin-bing1;WU Yan1;ZHANG Qi-nan1;JIN Yan2;QIAN Geng-sun2;TU Hong2 1.Department of Etiology;Qidong Liver Cancer Institute;Qidong 226200;China;2.Department of Centre Laboratory;Shanghai Cancer Institute;Renji Hospital;Shanghai Jiaotong University;Shanghai 200032;China
SUN Yan1;CHEN Tao-yang1;LU Pei-xin1;WANG Jin-bing1;WU Yan1;ZHANG Qi-nan1;JIN Yan2;QIAN Geng-sun2;TU Hong2 1.Department of Etiology;Qidong Liver Cancer Institute;Qidong 226200;China;2.Department of Centre Laboratory;Shanghai Cancer Institute;Renji Hospital;Shanghai Jiaotong University;Shanghai 200032;China
..............page:841-845
The inhibitory effect of Xiaoaiping injection combined with octreotide on the expression of cytokines Th1/Th2 in H22 liver cancer in mice
Wang Shu-min;Zhao He-ping Department of Oncology;First School of Clinical Medicine;Shanxi Medical University;Taiyuan 030001;China
Wang Shu-min;Zhao He-ping Department of Oncology;First School of Clinical Medicine;Shanxi Medical University;Taiyuan 030001;China
..............page:783-788
The association of genetic polymorphisms of BAG-1 and ERCC1 with the clinical response to platinum drugs in patients with advanced non-small cell lung cancer
WANG Ya-di;CHENG Jian;CHEN Jun-chen;WANG Yue;HA Min-wen Department of Oncology;First Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China
WANG Ya-di;CHENG Jian;CHEN Jun-chen;WANG Yue;HA Min-wen Department of Oncology;First Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China
..............page:824-829
Effect of calycosin on human breast cancer cell line MCF-7 in vitro
KUANG Wen-juan;LIU Li-tao;TAN Xian-shu;DUAN Ying;ZHOU Li-ming Department of Pharmacology;West China School of Preclinical and Forensic Medicine;Sichuan University;Chengdu 610041;China
KUANG Wen-juan;LIU Li-tao;TAN Xian-shu;DUAN Ying;ZHOU Li-ming Department of Pharmacology;West China School of Preclinical and Forensic Medicine;Sichuan University;Chengdu 610041;China
..............page:789-793
COX proportional-hazard regression analysis of prognostic factors in 52 adult patients with osteosarcoma
QI Wei-xiang;HE Ai-na;TANG Li-na;SHEN Zan;YAO Yang Department of Medical Oncology;Sixth People’s Hospital;Shanghai Jiaotong University;Shanghai 200233;China
QI Wei-xiang;HE Ai-na;TANG Li-na;SHEN Zan;YAO Yang Department of Medical Oncology;Sixth People’s Hospital;Shanghai Jiaotong University;Shanghai 200233;China
..............page:846-850
Influence of phosphatidylinositide 3-kinase inhibitor LY294002 on the expression of hypoxia inducible factor-1α and growth of human glioma U251 cells
CHU Sheng-hua;ZHU Zhi-an Departmet of Neurosurgery;Third People’s Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 201900;China
CHU Sheng-hua;ZHU Zhi-an Departmet of Neurosurgery;Third People’s Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 201900;China
..............page:819-823
..............page:818
Schedule-dependent cytotoxic synergism of docetaxel and sunitinib in EGFR-TKIs-resistant human non-small cell lung cancer cell line A549
PAN Feng1;TIAN Jing2;ZHANG Xu-chao3;PAN Yue-yin1 1.Department of Oncology;First Affiliated Hospital of Anhui Medical University;Hefei 230022;China;2.Department of Epidemiology and Biostatistics;School of Public Health;Anhui Medical University;Hefei 230032;China;3.Central Laboratory of Guangdong Lung Cancer Institute;Guangzhou 510080;China
PAN Feng1;TIAN Jing2;ZHANG Xu-chao3;PAN Yue-yin1 1.Department of Oncology;First Affiliated Hospital of Anhui Medical University;Hefei 230022;China;2.Department of Epidemiology and Biostatistics;School of Public Health;Anhui Medical University;Hefei 230032;China;3.Central Laboratory of Guangdong Lung Cancer Institute;Guangzhou 510080;China
..............page:806-812
Expression of melanoma antigen-A11 in breast cancer tissues and its promoting effect on the proliferation of breast cancer cells
LIAN Yi-shui1;SANG Mei-xiang2;ZHOU Xin-liang1;DING Chun-yan1;SHAN Bao-en1;2 1.Department of Research Center;2.Department of Immunology;Tumor Research Institute;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China
LIAN Yi-shui1;SANG Mei-xiang2;ZHOU Xin-liang1;DING Chun-yan1;SHAN Bao-en1;2 1.Department of Research Center;2.Department of Immunology;Tumor Research Institute;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China
..............page:830-834
Radiotherapy as primary treatment for stageⅠ-Ⅱ extranodal natural killer/T-cell lymphoma,nasal type:Analysis of treatment outcomes
SHEN Qian-wen1;2;PAN Zi-qiang1;2;GUO Ye1;2;MA Xue-jun1;2 1.Department of Radiation Oncology;Shanghai Cancer Center;Fudan University;Shanghai 200032;China;2.Department of Oncology;Fudan University Shanghai Medical School;Shanghai 200032;China
SHEN Qian-wen1;2;PAN Zi-qiang1;2;GUO Ye1;2;MA Xue-jun1;2 1.Department of Radiation Oncology;Shanghai Cancer Center;Fudan University;Shanghai 200032;China;2.Department of Oncology;Fudan University Shanghai Medical School;Shanghai 200032;China
..............page:835-840
Mitogen-activated protein kinase signaling pathway and glioma
ZHU Ting-zhun;XU Ying-hui Department of Neurosurgery;First Affiliated Hospital of Dalian Medical University;Dalian 116011;China
ZHU Ting-zhun;XU Ying-hui Department of Neurosurgery;First Affiliated Hospital of Dalian Medical University;Dalian 116011;China
..............page:871-874